Australian Pharmaceutical Industries on Monday received a non-binding proposal from Sigma Healthcare valuing it at A$773.5 million ($561.4 million), rivalling an offer from retail conglomerate Wesfarmers.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
